| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.0M | — | +98.9% |
| Cost of Revenue | $11.6M | — | +72.8% |
| Gross Profit | $14.5M | — | +126.3% |
| R&D Expense | $13.0M | — | +56.8% |
| SG&A Expense | $13.8M | — | +107.6% |
| Operating Income | -$12.3M | — | -44.4% |
| Pre-tax Income | -$20.9M | — | -172.4% |
| Income Tax | $464K | — | — |
| Net Income | -$21.3M | — | -178.4% |
| EPS (Basic) | -$1.74 | — | -155.9% |
| EPS (Diluted) | -$1.74 | — | -155.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $64.6M | +115.3% | — |
| Short-term Investments | $0 | — | — |
| Accounts Receivable | $19.5M | +53.1% | — |
| Inventory | $39.9M | +3.8% | — |
| Current Assets | $141.5M | +49.4% | — |
| Total Assets | $186.5M | +33.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.3M | — | -55.7% |
| Capital Expenditures | $600K | — | +8.3% |
| Investing Cash Flow | -$778K | — | -104.6% |
| Financing Cash Flow | $55.8M | — | — |
| Free Cash Flow | -$20.9M | — | -53.8% |
| Current Liabilities | $24.0M | +1.3% | — |
| Total Liabilities | $129.5M | +102.5% | — |
| Stockholders' Equity | -$178.1M | -12.0% | -26.9% |